Ligand Announces 2026 Investor Day in New York City

▤ Summary

Ligand Pharmaceuticals announced that it will host an Investor Day in New York City on December 8, 2026. The event will feature senior management presentations on strategy, recent investment activity, royalty portfolio performance, and the company’s long-term financial outlook. Ligand also highlighted its role as a royalty aggregator that finances late-stage biopharmaceutical development programs and licenses proprietary technologies like Captisol and NITRICIL. The announcement includes webcast access and notes that a detailed agenda will follow closer to the event.

▦ Linked Companies